Pregnancy after breast cancer in young women with certain gene changes
Part of Cancer, Skin clinical trials.
This study looks at pregnancy outcomes in young women who had breast cancer and carry certain gene changes (other than BRCA) that increase cancer risk. It aims to understand if pregnancy is safe and what the outcomes are.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with stage I to III invasive breast cancer between January 2000 and December 2025.
- You were 40 years old or younger at the time of your breast cancer diagnosis.
- You have a gene change (pathogenic variant) in one of these genes: TP53, PALB2, PTEN, CDH1, STK11, CHEK2, ATM, BARD1, RAD51C, or RAD51D.
- You do not have a known BRCA gene change.
- You have not had ovarian cancer or another cancer before your breast cancer diagnosis.
- Your breast cancer was not stage IV (spread to other parts of the body) at diagnosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the genetic changes in breast cancer patients, especially those with a family history or early onset. It may help doctors understand which genes are common in Chinese breast cancer patients and guide future treatment options.
This is an observational study that looks at how different cancer prevention approaches affect women with harmful (deleterious) BRCA1 or BRCA2 mutations. It may help improve future prevention and follow-up plans for women at higher inherited risk.
This study follows women who carry gene mutations that increase ovarian cancer risk to understand how preventive surgery affects their health, quality of life, and peace of mind. Researchers will track your outcomes over 3 years to help inform future treatment decisions for others at similar risk.
This study looks at how the immune system changes in people with breast cancer, using patient tissue samples. It may help researchers understand immune responses in young women and guide future cancer treatments.
This study looks at fertility, cancer outcomes, and children's health in women diagnosed with breast cancer at age 40 or younger. It aims to help you understand how breast cancer and its treatment may affect your ability to have children and your long-term health.
This study collects blood (and possibly tumor tissue) to learn how certain inherited gene changes relate to breast and ovarian cancer risk. It may help researchers understand which people are most likely to develop these cancers and how tumors differ in high-risk patients.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.